Tegeline

Intravenous immunoglobulin (IVIG)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tegeline, covering 2015-03-24 to 2015-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) [Phase 3]